JEB Technologies, Medovate Forge Australasia Distribution Agreement for CamPROBE

Medical device development/commercialization firms JEB Technologies and Medovate have signed a distribution agreement with Murray Medical Solutions Pty. Ltd. for the CamPROBE (Cambridge Prostate Biopsy Device) in Australia and New Zealand.

Urology expert Professor Vincent Gnanapragasam and his team at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust developed the CamPROBE device to facilitate transperineal prostate biopsies under local anaesthetic.

“It is truly exciting to see CamPROBE become available to patients in the Australasian market through this partnership. This is genuine progress on CamPROBE’s journey and another example of how an innovative clinical-academic like Vincent can turn an idea into a product that positively impacts patients’ lives,” Cambridge Enterprise Commercialization Director Terry Parlett said. “Such journeys are a team game and CamPROBE is a great example of how a passionate innovator, the NHS and academic ecosystem can work together with industry to deliver their innovations into the healthcare system.”

Cambridge Enterprise collaborated with healthcare innovation consultancy Health Tech Enterprise to secure intellectual property protection for the CamPROBE device. The agencies also helped obtain a grant from the National Institute for Health and Care Research (NIHR), which facilitated the refinement, clinical evaluation, and eventual CamPROBE commercialization.

The CamPROBE’s inventors collaborated with JEB Technologies to obtain the device’s CE marking.

“I’m thrilled to announce our new partnership with Murray Medical Solutions, a company that shares our commitment to delivering high-quality medical devices to healthcare professionals,” stated Stuart Thomson, vice president of Business Development, at Medovate and JEB Technologies Limited. “With their strong track record and specialization in medical device solutions, Murray Medical is an ideal distribution partner for our technology. Through this new partnership, the CamPROBE system (developed in collaboration with NHS clinical innovators) will become accessible to urologists across Australia and New Zealand, supporting broader use in clinical settings. We very much look forward to working with the Murray Medical team and we are excited to begin this journey with them.”

CamPROBE facilitates transperineal biopsy acquisition using simultaneous local anaesthetic delivery through an integrated needle. It is an alternative to transrectal and other transperineal devices, using only two body entry puncture points, resulting in low pain scores, and improved patient comfort and patient acceptability. Procedural access through the perineum reduces complications due to infections and sepsis, compared to transrectal procedures.

With a notable global increase in the demand for prostate cancer biopsies and diagnostics driven by aging populations, heightened awareness and extended screening programs, CamPROBE could potentially enhance the patient and healthcare experience.

“Murray Medical is delighted to have partnered with JEB Technologies and Medovate to become the exclusive distributor across Australia and New Zealand for the CamPROBE device,” Murray Medical Solutions Director Stuart Keighran commented. “We have always paid great attention to doctors and urologists’ needs and feedback and that is why we are honored to provide them with this technology for performing a prostate biopsy. Murray Medical has a long tradition in supplying parts of Australasia with solutions in urology and other therapy-area products that create benefits for clinicians and their patients. The addition of the CamPROBE system aligns perfectly with this tradition and allows us to keep improving patients’ quality of life. This agreement will allow urologists across Australia and New Zealand to offer their patients access to this technology, helping enhance patient care in the field of transperineal prostate biopsy.”

Cambridge Enterprise is the innovation arm of the University of Cambridge. Through Cambridge Enterprise, University of Cambridge research and expertise delivers life-changing outcomes with world-changing impact. The entity provides the diverse support needed by researchers, innovators and teams tackling current world challenges. Cambridge Enterprise connects, empowers, and enables the transformation of Cambridge research into purposeful social and economic global impacts.